AI assistant
REPLIGEN CORP — Director's Dealing 2022
Mar 3, 2022
30826_dirs_2022-03-02_0861ef98-23d8-4210-8544-d75ad50e866f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2022-02-27
Reporting Person: Hunt Anthony (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-27 | Common Stock | F | 2754 | $196.70 | Disposed | 193071 | Direct |
| 2022-02-28 | Common Stock | F | 3170 | $196.70 | Disposed | 189901 | Direct |
| 2022-02-28 | Common Stock | A | 30074 | $0.00 | Acquired | 219975 | Direct |
| 2022-02-28 | Common Stock | F | 13368 | $196.70 | Disposed | 206607 | Direct |
Footnotes
F1: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.
F2: Represents shares issued pursuant to a Performance Stock Unit ("PSU") award granted to the Issuer on February 28, 2019. The Compensation Committee authorized the issuance of the underlying shares based upon the Issuer's achievement of pre-established performance criteria set forth in the PSU award.
F3: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the settlement of the PSUs.